Suppr超能文献

一位 70 岁女性患有毛发红糠疹:当基因诊断影响治疗策略选择时,鉴定出一种致病性突变。

Identification of a pathogenic mutation in a 70-year-old woman with pityriasis rubra pilaris: when genetic diagnosis influences choice of treatment strategy.

机构信息

Department of Dermatology and Allergy Center, Odense University Hospital, Odense, Denmark

University of Southern Denmark, Odense, Syddanmark, Denmark.

出版信息

BMJ Case Rep. 2021 Jan 11;14(1):e235287. doi: 10.1136/bcr-2020-235287.

Abstract

Pityriasis rubra pilaris (PRP) is a rare dermatosis characterised by hyperkeratotic follicular papules, orange-red scaly plaques and palmoplantar keratoderma. The aetiology of the disease is in most cases unclear and treatment can be challenging. Familial cases of PRP may result from pathogenic variants in the caspase recruitment domain family member 14 (CARD14). We present a case of lifelong PRP in a 70-year-old woman, where genetic testing revealed a heterozygote missense variant c.412G>A, p.(Glu138Lys) in CARD14. Therapy with ustekinumab was initiated with remarkable effect, which improved the patient's quality of life significantly.

摘要

红糠疹(PRP)是一种罕见的皮肤病,其特征为角化过度的毛囊丘疹、橙红色鳞屑性斑块和掌跖角化病。该病的病因在大多数情况下尚不清楚,治疗可能具有挑战性。家族性 PRP 可能是由于半胱氨酸蛋白酶募集域家族成员 14(CARD14)的致病性变异引起的。我们报告了一例 70 岁女性终身 PRP 病例,基因检测显示 CARD14 中的杂合错义变异 c.412G>A,p.(Glu138Lys)。用乌司奴单抗进行治疗效果显著,显著改善了患者的生活质量。

相似文献

2
Beneficial effect of ustekinumab in familial pityriasis rubra pilaris with a new missense mutation in CARD14.
Br J Dermatol. 2018 Apr;178(4):969-972. doi: 10.1111/bjd.15462. Epub 2017 Oct 1.
3
CARD14-associated papulosquamous eruption: A spectrum including features of psoriasis and pityriasis rubra pilaris.
J Am Acad Dermatol. 2018 Sep;79(3):487-494. doi: 10.1016/j.jaad.2018.02.034. Epub 2018 Mar 1.
4
CARD14 Glu138 mutation in familial pityriasis rubra pilaris does not warrant differentiation from familial psoriasis.
J Dermatol. 2016 Feb;43(2):187-9. doi: 10.1111/1346-8138.13008. Epub 2015 Jul 1.
5
The management and genetic background of pityriasis rubra pilaris: a single-centre experience.
J Eur Acad Dermatol Venereol. 2019 May;33(5):944-949. doi: 10.1111/jdv.15455. Epub 2019 Mar 3.
6
Clinical response to ustekinumab in familial pityriasis rubra pilaris caused by a novel mutation in CARD14.
Br J Dermatol. 2014 Aug;171(2):420-2. doi: 10.1111/bjd.12952. Epub 2014 Aug 6.
7
CARD14-mutations in pityriasis rubra pilaris and therapeutic response to ustekinumab - a hypothesis.
J Dtsch Dermatol Ges. 2020 Nov;18(11):1312-1315. doi: 10.1111/ddg.14218. Epub 2020 Sep 2.
8
A Review on Pityriasis Rubra Pilaris.
Am J Clin Dermatol. 2018 Jun;19(3):377-390. doi: 10.1007/s40257-017-0338-1.
9
Pityriasis Rubra Pilaris Type V as an Autoinflammatory Disease by CARD14 Mutations.
JAMA Dermatol. 2017 Jan 1;153(1):66-70. doi: 10.1001/jamadermatol.2016.3601.
10
Familial pityriasis rubra pilaris is caused by mutations in CARD14.
Am J Hum Genet. 2012 Jul 13;91(1):163-70. doi: 10.1016/j.ajhg.2012.05.010. Epub 2012 Jun 14.

引用本文的文献

1
Clinical and Genetic Findings in Patients With Palmoplantar Keratoderma.
JAMA Dermatol. 2025 Feb 1;161(2):157-166. doi: 10.1001/jamadermatol.2024.4824.
2
Severe atypical juvenile pityriasis rubra pilaris diagnosed in adulthood with a dramatic improvement with ustekinumab.
Skin Health Dis. 2024 Apr 11;4(4):e389. doi: 10.1002/ski2.389. eCollection 2024 Aug.
3
Pityriasis Rubra Pilaris: An Updated Review of Clinical Presentation, Etiopathogenesis, and Treatment Options.
Am J Clin Dermatol. 2024 Mar;25(2):243-259. doi: 10.1007/s40257-023-00836-x. Epub 2023 Dec 30.
4
Biologic Therapies for the Management of Cutaneous Findings in Genodermatoses: A Review.
Am J Clin Dermatol. 2022 Sep;23(5):673-688. doi: 10.1007/s40257-022-00700-4. Epub 2022 May 23.

本文引用的文献

2
Secukinumab in pityriasis rubra pilaris: A case series demonstrating variable response and the need for minimal clinical datasets.
JAAD Case Rep. 2018 May 7;4(5):500-505. doi: 10.1016/j.jdcr.2018.02.007. eCollection 2018 Jun.
3
CARD14-associated papulosquamous eruption: A spectrum including features of psoriasis and pityriasis rubra pilaris.
J Am Acad Dermatol. 2018 Sep;79(3):487-494. doi: 10.1016/j.jaad.2018.02.034. Epub 2018 Mar 1.
4
Pityriasis rubra pilaris: algorithms for diagnosis and treatment.
J Eur Acad Dermatol Venereol. 2018 Jun;32(6):889-898. doi: 10.1111/jdv.14761. Epub 2018 Jan 17.
5
Beneficial effect of ustekinumab in familial pityriasis rubra pilaris with a new missense mutation in CARD14.
Br J Dermatol. 2018 Apr;178(4):969-972. doi: 10.1111/bjd.15462. Epub 2017 Oct 1.
7
CARD14 Glu138 mutation in familial pityriasis rubra pilaris does not warrant differentiation from familial psoriasis.
J Dermatol. 2016 Feb;43(2):187-9. doi: 10.1111/1346-8138.13008. Epub 2015 Jul 1.
8
Clinical response to ustekinumab in familial pityriasis rubra pilaris caused by a novel mutation in CARD14.
Br J Dermatol. 2014 Aug;171(2):420-2. doi: 10.1111/bjd.12952. Epub 2014 Aug 6.
9
Familial pityriasis rubra pilaris is caused by mutations in CARD14.
Am J Hum Genet. 2012 Jul 13;91(1):163-70. doi: 10.1016/j.ajhg.2012.05.010. Epub 2012 Jun 14.
10
PSORS2 is due to mutations in CARD14.
Am J Hum Genet. 2012 May 4;90(5):784-95. doi: 10.1016/j.ajhg.2012.03.012. Epub 2012 Apr 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验